Clinical Trial Update: Characterization of the Immunometabolic Signature in Long COVID-19. [NA]

View source ↗

Summary

A completed clinical trial exploring the immunometabolic signature of Long COVID to understand its underlying biology.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Post-acute Sequelae of Sars-cov-2 Infection

Snippet

Sponsor: University Hospital, Angers | Conditions: Long COVID | NA | Status: COMPLETED